loading
前日終値:
$64.51
開ける:
$64.22
24時間の取引高:
857.38K
Relative Volume:
0.65
時価総額:
$5.28B
収益:
-
当期純損益:
$-153.72M
株価収益率:
-31.35
EPS:
-2
ネットキャッシュフロー:
$-103.81M
1週間 パフォーマンス:
-6.15%
1か月 パフォーマンス:
-6.59%
6か月 パフォーマンス:
+118.01%
1年 パフォーマンス:
+289.68%
1日の値動き範囲:
Value
$62.00
$64.41
1週間の範囲:
Value
$62.00
$67.31
52週間の値動き範囲:
Value
$11.39
$70.40

Verona Pharma Plc Adr Stock (VRNA) Company Profile

Name
名前
Verona Pharma Plc Adr
Name
セクター
Healthcare (1166)
Name
電話
011-44-0-2032834200
Name
住所
3 MORE LONDON RIVERSIDE, LONDON
Name
職員
0
Name
Twitter
@VeronaPharma
Name
次回の収益日
2024-11-04
Name
最新のSEC提出書
Name
VRNA's Discussions on Twitter

VRNA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
VRNA
Verona Pharma Plc Adr
62.70 5.28B 0 -153.72M -103.81M -2.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.69 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
637.36 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
589.15 35.93B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
268.46 34.75B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
267.39 28.24B 3.81B -644.79M -669.77M -6.24

Verona Pharma Plc Adr Stock (VRNA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-10 開始されました ROTH MKM Buy
2024-10-03 開始されました Wells Fargo Overweight
2023-05-22 再開されました Jefferies Buy
2022-09-19 再開されました Wedbush Outperform
2022-08-26 開始されました Piper Sandler Overweight
2021-09-13 開始されました H.C. Wainwright Buy
2020-08-25 開始されました Jefferies Buy
2020-08-10 開始されました Canaccord Genuity Buy
2019-04-18 開始されました BTIG Research Buy
すべてを表示

Verona Pharma Plc Adr (VRNA) 最新ニュース

pulisher
Mar 28, 2025

Verona Pharma secures $450 million credit facility on better terms By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Verona Pharma secures $450 million credit facility on better terms - Investing.com India

Mar 28, 2025
pulisher
Mar 25, 2025

The growth track for Cracker Barrel Old Country Store Inc (CBRL) has changed recently - SETE News

Mar 25, 2025
pulisher
Mar 18, 2025

Verona Pharma Plc ADR (NASDAQ: VRNA) Up 298.80% This Year: What Is Going To Happen Next - Stocks Register

Mar 18, 2025
pulisher
Mar 13, 2025

Verona Pharma’s chief medical officer sells shares worth $661,941 By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 13, 2025

Verona Pharma’s chief medical officer sells shares worth $661,941 - Investing.com India

Mar 13, 2025
pulisher
Mar 10, 2025

Keeping an Eye on Gilead Sciences, Inc (GILD) After Insider Trading Activity - Knox Daily

Mar 10, 2025
pulisher
Mar 10, 2025

McEwen Mining Inc (MUX) Becoming More Attractive for Investors - Knox Daily

Mar 10, 2025
pulisher
Mar 10, 2025

Morgan Stanley Upgrades Solaredge Technologies Inc (SEDG) to an Equal-weight from an Underweight - Knox Daily

Mar 10, 2025
pulisher
Mar 10, 2025

Verona Pharma at Leerink Global Healthcare: Eutuvera’s Promising Launch By Investing.com - Investing.com UK

Mar 10, 2025
pulisher
Feb 28, 2025

Earnings call transcript: Verona Pharma Q4 2024 beats EPS & revenue forecasts By Investing.com - Investing.com South Africa

Feb 28, 2025
pulisher
Feb 27, 2025

Verona Pharma stock surges as Q4 revenue soars past estimates - Investing.com India

Feb 27, 2025
pulisher
Feb 27, 2025

Verona Pharma stock surges as Q4 revenue soars past estimates By Investing.com - Investing.com Canada

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings call transcript: Verona Pharma Q4 2024 beats EPS & revenue forecasts - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

Verona Pharma plc (NASDAQ:VRNA) Q4 2024 Earnings Call Transcript - MSN

Feb 27, 2025
pulisher
Feb 27, 2025

Verona Pharma ADR earnings beat by $0.02, revenue topped estimates - Investing.com UK

Feb 27, 2025
pulisher
Feb 21, 2025

A company insider recently sold 640,264 shares of Verona Pharma Plc ADR [VRNA]. Should You Sale? - Knox Daily

Feb 21, 2025
pulisher
Feb 13, 2025

Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update - GlobeNewswire Inc.

Feb 13, 2025
pulisher
Feb 12, 2025

Verona Pharma stock soars to all-time high of $62.09 - Investing.com India

Feb 12, 2025
pulisher
Feb 12, 2025

Verona Pharma stock soars to all-time high of $62.09 By Investing.com - Investing.com South Africa

Feb 12, 2025
pulisher
Feb 12, 2025

Canaccord raises Verona Pharma target to $72; maintains buy By Investing.com - Investing.com South Africa

Feb 12, 2025
pulisher
Feb 11, 2025

Investor’s Delight: Lithium Americas Corp (NewCo) (LAC) Closes Weak at 2.97, Down -1.98 - The Dwinnex

Feb 11, 2025
pulisher
Feb 11, 2025

There is no doubt that Verona Pharma Plc ADR (VRNA) ticks all the boxes. - SETE News

Feb 11, 2025
pulisher
Feb 11, 2025

Analyzing Verona Pharma Plc ADR (VRNA) After Recent Trading Activity - Knox Daily

Feb 11, 2025
pulisher
Feb 11, 2025

Rumble Inc (RUM)’s Market Momentum: Closing Strong at 12.25, Down -3.92 - The Dwinnex

Feb 11, 2025
pulisher
Feb 11, 2025

Market Recap Check: Lineage Cell Therapeutics Inc (LCTX)’s Negative Finish at 0.66, Up/Down -2.12 - The Dwinnex

Feb 11, 2025
pulisher
Feb 11, 2025

A History of Outperforming Analyst Forecasts and Beating the Odds: OrganiGram Holdings Inc (OGI) - SETE News

Feb 11, 2025
pulisher
Feb 06, 2025

Are Smart Investors Making the Right Decision? Verona Pharma Plc ADR (VRNA) - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

Healthy Upside Potential: Solidion Technology Inc (STI) - SETE News

Feb 06, 2025
pulisher
Feb 05, 2025

Stock Surge: XPO Inc (XPO) Closes at 131.50, Marking a 2.24 Increase/Decrease - The Dwinnex

Feb 05, 2025
pulisher
Feb 05, 2025

Closing Figures Unveiled: Diageo plc ADR (DEO) Drop -0.84, Closes at 115.95 - The Dwinnex

Feb 05, 2025
pulisher
Feb 05, 2025

Market Watch Highlights: Verona Pharma Plc ADR (VRNA) Ends on an Upturn Note at 59.94 - The Dwinnex

Feb 05, 2025
pulisher
Feb 05, 2025

Market Momentum Report: Lemonade Inc (LMND)’s Positive Close at 33.99 - The Dwinnex

Feb 05, 2025
pulisher
Feb 05, 2025

Stock Market News and Commentary - Barchart

Feb 05, 2025
pulisher
Feb 04, 2025

Verona Pharma Keeps Hitting New Highs - Barchart

Feb 04, 2025
pulisher
Feb 04, 2025

An Analysis of Knowles Corp (KN)’s Potential Price Growth - Knox Daily

Feb 04, 2025
pulisher
Feb 04, 2025

Checking in on Verona Pharma Plc ADR (VRNA) after recent insiders movement - Knox Daily

Feb 04, 2025
pulisher
Feb 04, 2025

A closer look at Centessa Pharmaceuticals plc ADR (CNTA) is warranted - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

Have you been able to find a good deal on Verona Pharma Plc ADR’s shares? - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

The Agilon Health Inc (AGL) had a good session last reading, didn’t it? - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

How should investors view Relay Therapeutics Inc (RLAY)? - US Post News

Feb 04, 2025
pulisher
Jan 21, 2025

Verona Pharma stock target upgraded, retains buy on Q4 results - MSN

Jan 21, 2025
pulisher
Jan 21, 2025

Verona Pharma stock target upgraded, retains buy on Q4 results By Investing.com - Investing.com South Africa

Jan 21, 2025
pulisher
Jan 17, 2025

Looking For A Top Momentum Pick? Why Valley National Bancorp (NASDAQ: VLY) Is A Great Choice - Stocks Register

Jan 17, 2025
pulisher
Jan 17, 2025

Hertz Global Holdings Inc (NASDAQ: HTZ): Overvalued Compared To Others? - Stocks Register

Jan 17, 2025
pulisher
Jan 17, 2025

Verona Pharma Plc ADR (VRNA) Outlook: Looking Back For Insights - Stocks Register

Jan 17, 2025
pulisher
Jan 16, 2025

Why Verona Pharma, A Triple-Digit Gainer In 2024, Surged Another 19% This Week - Yahoo! Voices

Jan 16, 2025
pulisher
Jan 08, 2025

Verona Pharma stock target increased, keeps buy on Q4 sales By Investing.com - Investing.com South Africa

Jan 08, 2025
pulisher
Jan 07, 2025

Verona Pharma stock soars to all-time high of $49.05 - Investing.com India

Jan 07, 2025
pulisher
Jan 03, 2025

Here are some of BTIG's top picks for the first half of 2025 - Investing.com

Jan 03, 2025
pulisher
Dec 30, 2024

Verona Pharma stock soars to all-time high of $47 amid robust gains By Investing.com - Investing.com South Africa

Dec 30, 2024

Verona Pharma Plc Adr (VRNA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$77.99
price up icon 0.39%
$306.97
price down icon 0.34%
$31.37
price down icon 0.88%
$20.32
price down icon 1.36%
$94.95
price down icon 0.47%
biotechnology ONC
$267.39
price up icon 1.82%
大文字化:     |  ボリューム (24 時間):